Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PMV Pharmaceuticals Inc
PMVP | US
1.47
USD0.12
8.89%
PMVP | US
Loading StockChartView...
About PMV Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
14/04/2026
Close
1.47
Open
1.38
High
1.49
Low
1.35
PMV Pharmaceuticals Inc. a precision oncology company engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586 a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations including R273H R273C R175H G245S R248Q and R282W as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals Inc. and changed its name to PMV Pharmaceuticals Inc. in July 2013. PMV Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Cranbury New Jersey.
View LessPMVP | US
Risk
61.8
Sharpe
0.88
Luna's Score
57/100
Recommendation
Hold
Luna says (PMVP | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
67.4%1 month
61.8%3 months
90.5%6 months
73.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.36
Debt to equity
0.06
Debt to assets
0.05
Ent. to EBITDA
1.24
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-74.84M
MarketCap
75.73M
MarketCap(USD)
75.73M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-22.62
Short ratio
5.82
Short perc.
2.38
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.28
Range1M
0.39
Range3M
0.86
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
3.03
Price X volume
1.90M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.24 | 0.53 | Expensive |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.36 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 90.46 | 72.80 | Riskier |
| Debt to Equity | 0.06 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 75.73M | 3.66B | Emerging |
